<\/p>\n
Minirin<\/strong> is a oral tablet of desmopressin<\/strong> (0.1 mg tablet) — a synthetic analogue of the natural antidiuretic hormone (vasopressin). It is used for central diabetes insipidus<\/strong> (the pituitary disorder, NOT the common type 2 diabetes mellitus), primary nocturnal enuresis (bedwetting)<\/strong>, \u03ba\u03b1\u03b9 nocturia<\/strong>. Desmopressin reduces urine production by up to 90% by promoting water reabsorption in the collecting ducts of the kidney. Onset: 1–2 hours; duration: 8–12 hours. Critical safety rule — restrict fluids for 1 hour before and 8 hours after each dose<\/strong> to prevent dangerous hyponatraemia (low sodium, which can cause seizures). Avoid in heart failure, moderate-to-severe renal impairment, hyponatraemia, and SIADH. Desmopressin is NOT a treatment for type 2 diabetes or insulin resistance<\/strong> — the two conditions share only the word “diabetes”.<\/p>\n<\/div>\n \ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n \u03a4\u03b1 \u03b3\u03b5\u03bd\u03cc\u03c3\u03b7\u03bc\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03ac \u03bc\u03b1\u03c2 \u03c0\u03c1\u03bf\u03ad\u03c1\u03c7\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd WHO-GMP \u03ba\u03b1\u03b9 \u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c0\u03b1\u03b3\u03ba\u03bf\u03c3\u03bc\u03af\u03c9\u03c2 \u03c3\u03b5 \u03b4\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae, \u03b1\u03c0\u03bb\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u2014 \u03c7\u03c9\u03c1\u03af\u03c2 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5 \u03c3\u03c4\u03bf \u03b5\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u03c4\u03bf\u03c5 \u03b4\u03ad\u03bc\u03b1\u03c4\u03bf\u03c2. \u039f\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u03b4\u03c1\u03bf\u03bc\u03bf\u03bb\u03bf\u03b3\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03bc\u03ad\u03c3\u03c9 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5 \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae (\u03bf\u03b9 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03b1\u03c6\u03ad\u03c2 \u03b5\u03ba\u03ba\u03b1\u03b8\u03ac\u03c1\u03b9\u03c3\u03b7\u03c2 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03c5\u03bd \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ce\u03bd \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u2014 \u03c0\u03bf\u03c4\u03ad \u201cMedsBase\u201d \u03ae \u03bf\u03c0\u03bf\u03b9\u03bf\u03b4\u03ae\u03c0\u03bf\u03c4\u03b5 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5). \u0393\u03af\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b4\u03b5\u03ba\u03c4\u03ad\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03c1\u03c5\u03c0\u03c4\u03bf\u03bd\u03bf\u03bc\u03af\u03c3\u03bc\u03b1\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03c1\u03b1\u03c0\u03b5\u03b6\u03b9\u03ba\u03ae \u03bc\u03b5\u03c4\u03b1\u03c6\u03bf\u03c1\u03ac SEPA. \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2 \u0395\u03be\u03b1\u03c3\u03c6\u03b1\u03bb\u03af\u03c3\u03b5\u03ce\u03c2 \u03bc\u03b1\u03c2.<\/p>\n Minirin is a oral tablet formulation of desmopressin acetate<\/strong> (0.1 mg tablet), manufactured by Ferring Pharmaceuticals. Supplied in packs of 30, 60, 90 or 180 tablets.<\/p>\n Desmopressin (DDAVP) is a synthetic analogue of arginine vasopressin (ADH)<\/strong>, the body’s natural antidiuretic hormone. It has been modified in two ways: a deamination at position 1 (increasing resistance to enzymatic breakdown) and substitution of L-arginine with D-arginine at position 8 (removing the vasoconstrictor effect). The result is a drug with strong antidiuretic action but minimal blood-pressure effects<\/strong>.<\/p>\n Desmopressin is approved for three main groups of conditions:<\/p>\n Off-label: mild haemophilia A and type 1 von Willebrand disease (raises factor VIII and von Willebrand factor levels short-term), uraemic bleeding before procedures.<\/p>\n \u038c\u03c7\u03b9.<\/strong> “Diabetes insipidus” and “diabetes mellitus” share the Latin word diabetes<\/em> (meaning “to pass through” — referring to excess urine output) but are completely different conditions:<\/p>\n If you are looking for a medicine to lower blood sugar, please see the metformin, SGLT-2, or DPP-4 product pages instead.<\/p>\n Desmopressin binds to V2 receptors<\/strong> on cells lining the collecting ducts of the kidney. This triggers insertion of aquaporin-2 water channels<\/strong> into the cell membrane, allowing water to be reabsorbed from urine back into the blood. Urine output falls and urine concentration rises.<\/p>\n In central diabetes insipidus, this replaces the missing hormone. In primary nocturnal enuresis and nocturia, it reduces the volume of urine produced overnight — so the bladder does not fill to the point of leakage or waking.<\/p>\n Desmopressin has essentially no effect on V1 receptors<\/strong>, which means it does not cause vasoconstriction or raise blood pressure (unlike natural vasopressin).<\/p>\n Central diabetes insipidus (adults):<\/strong> starting dose 0.1 mg two or three times daily. Titrate to clinical response (urine output, thirst, nocturia). Usual maintenance: 0.1–0.8 mg\/day in divided doses. Maximum 1.2 mg\/day.<\/p>\n Primary nocturnal enuresis (children aged 6+ and adults):<\/strong> 0.2 mg at bedtime; increase to 0.4 mg if response inadequate after 1–2 weeks. Restrict fluids from 1 hour before until 8 hours after each dose<\/strong> to prevent hyponatraemia.<\/p>\n Nocturia (adults < 65 years):<\/strong> 0.05–0.2 mg at bedtime. Higher doses are avoided in older adults because of hyponatraemia risk.<\/p>\n All patients:<\/strong> monitor serum sodium, particularly in the first 2 weeks and after any dose change. Symptoms of low sodium — headache, nausea, confusion, seizures — require immediate medical attention.<\/p>\n \u03a3\u03c5\u03c7\u03bd\u03ad\u03c2:<\/strong><\/p>\n Uncommon but important — hyponatraemia and water intoxication:<\/strong><\/p>\n \u03a4\u03bf main serious risk<\/strong> of desmopressin is dilutional hyponatraemia<\/strong> — low sodium caused by water retention when fluids are not restricted. Early symptoms are headache, nausea, weight gain, and lethargy. Severe hyponatraemia can cause seizures and coma. Prevention: strict fluid restriction around each dose. Risk is highest in older adults, those on SSRIs, NSAIDs, or thiazides, and during acute illness.<\/p>\n Other uncommon:<\/strong> hypersensitivity, conjunctival inflammation, small increases in blood pressure.<\/p>\n Store Minirin below 25°C in a dry place (tablets) or at 2–8°C until first use, then below 25°C once opened (nasal spray). Keep out of reach of children. Check specific label for expiry and in-use duration.<\/p>\n No. Desmopressin treats diabetes insipidus<\/em> (a hormone\/water-balance problem) and bedwetting\/nocturia. It does not lower blood sugar and is not used for type 2 diabetes. The two conditions share only the word “diabetes”.<\/p>\n Restrict fluids from 1 hour before to 8 hours after each dose. The exact amount depends on body size and climate, but most patients are advised to drink only when thirsty during this window and to stop drinking earlier if urine output does not increase. Never “force fluids” on desmopressin — this is the commonest cause of hyponatraemia.<\/p>\n These may be early signs of hyponatraemia. Stop the drug, stop drinking, and seek medical attention.<\/strong> A blood sodium test will confirm. Severe hyponatraemia can cause seizures and is a medical emergency.<\/p>\n Yes, in children aged 6 and over and in adults with persistent primary nocturnal enuresis, desmopressin is a standard treatment — tablets are preferred over nasal spray for this indication. Usual dose: 0.2 mg at bedtime (titrate up to 0.4 mg if needed). Strict fluid restriction in the evening is essential.<\/p>\n With caution. Adults > 65 have a significantly higher risk of hyponatraemia on desmopressin, and some regulators (including the UK MHRA) advise against using it for nocturia in this age group. If used, start at the lowest dose and monitor sodium closely.<\/p>\n You can order Minirin (0.1 mg tablet) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine Ferring Pharmaceuticals manufacturer stock.<\/p>\n <\/p>\n \u0386\u03bb\u03bb\u03b1 \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03b1 \u03c3\u03b5 \u03a7\u03c1\u03cc\u03bd\u03b9\u03b5\u03c2 \u03a0\u03b1\u03b8\u03ae\u03c3\u03b5\u03b9\u03c2<\/strong> \u03c0\u03bf\u03c5 \u03bf\u03b9 \u03c0\u03b5\u03bb\u03ac\u03c4\u03b5\u03c2 \u03b5\u03be\u03b5\u03c4\u03ac\u03b6\u03bf\u03c5\u03bd \u03b5\u03c0\u03af\u03c3\u03b7\u03c2:<\/p>\n \u2705 Controls bedwetting Minirin contains Desmopressin.<\/p>","protected":false},"featured_media":56553,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[4114,4115],"class_list":{"0":"post-56552","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-desmopressin","11":"product_tag-minirin","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product\/56552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/comments?post=56552"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media\/56553"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media?parent=56552"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_brand?post=56552"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat?post=56552"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_tag?post=56552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n
What Is Minirin?<\/h2>\n
What Is Minirin Used For?<\/h2>\n
\n
Is Desmopressin for Type 2 Diabetes?<\/h2>\n
\n
How Does Minirin Work?<\/h2>\n
\u0394\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03af\u03b1 \u03ba\u03b1\u03b9 \u03a7\u03bf\u03c1\u03ae\u03b3\u03b7\u03c3\u03b7<\/h2>\n
\n
\u03a0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b5\u03c2<\/h2>\n
\n
\u0391\u03bb\u03bb\u03b7\u03bb\u03b5\u03c0\u03b9\u03b4\u03c1\u03ac\u03c3\u03b5\u03b9\u03c2 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd<\/h2>\n
\n
Who Should Not Take Minirin?<\/h2>\n
\n
\u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7<\/h2>\n
\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2 \u0395\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n
Is desmopressin the same as a medicine for type 2 diabetes?<\/h3>\n
How much water can I drink while taking Minirin?<\/h3>\n
What if I get a headache, nausea, or confusion on Minirin?<\/h3>\n
Can I take Minirin for bedwetting?<\/h3>\n
Can older adults take Minirin?<\/h3>\n
Where can I buy Minirin online?<\/h3>\n
Related Medications<\/h2>\n
\n
\u03a3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ad\u03c2 \u0395\u03bd\u03b1\u03bb\u03bb\u03b1\u03ba\u03c4\u03b9\u03ba\u03ad\u03c2<\/h3>\n
\n
\n\u2705 Treats diabetes insipidus
\n\u2705 Manages excessive thirst
\n\u2705 Reduces urination frequency
\n\u2705 Prevents dehydration<\/p>\n